BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial

Press/Media

Period	3 Mar 2020

Media coverage

Title	BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial
Media name/outlet	Cardiac Vascular News
Country/Territory	United States
Date	3/03/20
URL	cardiacvascularnews.com/bioventrix-announces-ralph-stephan-von-bardeleben-md-as-co-principal-investigator-of-the-revive-hf-clinical-trial/
Persons	Gregg Stone